Annual report pursuant to Section 13 and 15(d)

Acquisition (Details Narrative)

v3.24.1.u1
Acquisition (Details Narrative) - USD ($)
12 Months Ended
Dec. 01, 2023
Mar. 01, 2023
Dec. 31, 2023
Business Acquisition [Line Items]      
Payment to acquire business   $ 500,000 $ 500,000
C.G. Laboratories Inc. [Member]      
Business Acquisition [Line Items]      
Minority percentage   50.00%  
Kenkoderm Acquisition [Member]      
Business Acquisition [Line Items]      
Cash payment for acquire assets $ 546,500    
Payments to acquire businesses, cash earn-out 136,625    
Net tangible assets acquired $ 169,000    
Joint Venture [Member]      
Business Acquisition [Line Items]      
Acquisition percentage   50.00%  
CG Labs [Member]      
Business Acquisition [Line Items]      
Cash payment for acquire assets     500,000
Net tangible assets acquired     $ 1,000,000
Acquisition percentage   50.00%